DMAB Trademark

Trademark Overview

On Wednesday, October 17, 2018, a trademark application was filed for DMAB with the United States Patent and Trademark Office. The USPTO has given the DMAB trademark a serial number of 88158692. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 21, 2022. This trademark is owned by Inovio Pharmaceuticals, Inc.. The DMAB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer and infectious diseases
dmab

General Information

Serial Number88158692
Word MarkDMAB
Filing DateWednesday, October 17, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 21, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 29, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInovio Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPlymouth Meeting, PA 19462
Party NameInovio Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPlymouth Meeting, PA 19462

Trademark Events

Event DateEvent Description
Monday, November 21, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 21, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, April 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 21, 2022SOU EXTENSION 5 GRANTED
Friday, April 15, 2022SOU EXTENSION 5 FILED
Wednesday, April 20, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 15, 2022TEAS EXTENSION RECEIVED
Tuesday, October 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 15, 2021SOU EXTENSION 4 GRANTED
Friday, October 15, 2021SOU EXTENSION 4 FILED
Friday, October 15, 2021TEAS EXTENSION RECEIVED
Saturday, April 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 15, 2021SOU EXTENSION 3 GRANTED
Thursday, April 15, 2021SOU EXTENSION 3 FILED
Thursday, April 15, 2021TEAS EXTENSION RECEIVED
Saturday, October 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 15, 2020SOU EXTENSION 2 GRANTED
Thursday, October 15, 2020SOU EXTENSION 2 FILED
Thursday, October 15, 2020TEAS EXTENSION RECEIVED
Friday, April 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 15, 2020SOU EXTENSION 1 GRANTED
Wednesday, April 15, 2020SOU EXTENSION 1 FILED
Wednesday, April 15, 2020TEAS EXTENSION RECEIVED
Tuesday, October 15, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 20, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 20, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 31, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 12, 2019ASSIGNED TO LIE
Tuesday, July 2, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 11, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 10, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 8, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, December 8, 2018NON-FINAL ACTION E-MAILED
Saturday, December 8, 2018NON-FINAL ACTION WRITTEN
Friday, November 30, 2018ASSIGNED TO EXAMINER
Monday, October 29, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 20, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

dmab treatment antibodies cancer infectious diseases monoclonal encode containing preparations nucleic